Renaissance Capital

Nasdaq

Biotech

In spite of COVID-19, biotech IPOs have had a record year

It didn’t look good for IPOs when the pandemic took hold, but biotech IPOs have been the star of ther show this year.

Amirah Al Idrus Dec 22, 2020 7:00am

Nasdaq

IPO market sealed shut for the foreseeable future: report

Mar 20, 2020 8:00am

Nasdaq

PPD sets out $1B IPO plans as it launches new China labs

Jan 13, 2020 7:20am